NEW YORK, Oct. 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
GlobalData, the industry analysis specialist, has released its new report, "Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global pneumonia therapeutics market, identifying the key trends shaping and driving the market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global pneumonia therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
GlobalData estimated the pneumonia therapeutics market to be worth $1,988m in 2010. It is forecast to decline at a Compound Annual Growth Rate (CAGR) of 1.1% to reach $1,815m by 2018. The market deteriorated during 2005-2010 owing to the patent expiries of major drugs such as Zithromax (azithromycin), Zosyn (piperacillin-tazobacta
Copyright©2010 PR Newswire.
All rights reserved